These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 241494)

  • 21. [Comparative pharmacokinetics of the beta-1 receptor blookader celiprolol after a single oral administration in subjects with health kidneys and in patients with impaired renal function].
    Schmidt P; Takacs F; Pittner H; Minar E; Balcke P; Zazgornik J; Deutsch E
    Wien Klin Wochenschr; 1985 Sep; 97(18):729-32. PubMed ID: 2866633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiological disposition and metabolism of timolol in man and laboratory animals.
    Tocco DJ; Duncan AE; Delauna FA; Hucker HB; Gruber VF; Vandenheuvel WJ
    Drug Metab Dispos; 1975; 3(5):361-70. PubMed ID: 241617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical investigation of o-(2-hydroxy-3-(tert.-butylamino)-propoxy)-benzonitrile under glucose load by means of continuous recording].
    Regula H; Papner B
    Arzneimittelforschung; 1974 Sep; 24(9):1328-30. PubMed ID: 4154767
    [No Abstract]   [Full Text] [Related]  

  • 24. Absorption of the beta-adrenergic-blocking agent, nadolol, by mice, rats, hamsters, rabbits, dogs, monkeys, and man: an unusual species difference.
    Dreyfuss J; Shaw JM; Ross JJ
    Xenobiotica; 1978 Aug; 8(8):503-8. PubMed ID: 29379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative determination of tertatolol in biological fluids by gas chromatography-mass spectrometry.
    Staveris S; Blaise P; Efthymiopoulos C; Schneider M; Jamet G; Jung L; Koffel JC
    J Chromatogr; 1985 Apr; 339(1):97-103. PubMed ID: 2862155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological profile of a new beta-adrenoceptor blocker, 4-[3-(tert-butylamino)-2-hydroxypropoxy]-N-methylisocarbostyril hydrochloride (N-696).
    Nakagawa Y; Sugai T; Chin WP; Shibuya T; Hashimoto K; Imai S
    Arzneimittelforschung; 1984; 34(2):194-9. PubMed ID: 6144313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tazolol (1-isopropylamino-3-(2-thiazoloxy)-2-propanol) as a beta-adrenergic blocker.
    Vauquelin G; Lacombe ML; Guellaen G; Strosberg AD; Hanoune J
    Biochem Pharmacol; 1976 Dec; 25(23):2605-8. PubMed ID: 10927
    [No Abstract]   [Full Text] [Related]  

  • 28. Determination of the new beta-blocker bisoprolol and of metoprolol, atenolol and propranolol in plasma and urine by high-performance liquid chromatography.
    Bühring KU; Garbe A
    J Chromatogr; 1986 Oct; 382():215-24. PubMed ID: 2878004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 30. Vortex-assisted liquid-liquid extraction combined with field-amplified sample injection and sweeping micellar electrokinetic chromatography for improved determination of β-blockers in human urine.
    Jouyban A; Sorouraddin MH; Farajzadeh MA; Somi MH; Fazeli-Bakhtiyari R
    Talanta; 2016; 149():298-309. PubMed ID: 26717845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional studies of the first selective beta 3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes.
    Nisoli E; Tonello C; Landi M; Carruba MO
    Mol Pharmacol; 1996 Jan; 49(1):7-14. PubMed ID: 8569714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of falintolol II. Absorption, distribution and elimination from tissues and organs following ocular administration and intravenous injection of falintolol in albino rabbits.
    Andermann G; Guggenbuhl P; de Burlet G; Himber J
    Methods Find Exp Clin Pharmacol; 1989 Dec; 11(12):747-54. PubMed ID: 2576299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of tertatolol enantiomers in biological fluids by high-performance liquid chromatography.
    Lave T; Efthymiopoulos C; Koffel JC; Jung L
    J Chromatogr; 1991 Dec; 572(1-2):203-10. PubMed ID: 1687817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of beta-adrenoceptors on rat skeletal muscle cells grown in vitro.
    Disatnik MH; Sampson SR; Shainberg A
    Biochem Pharmacol; 1990 Sep; 40(5):1043-8. PubMed ID: 1975171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Circulatory effects of a new specific beta adrenergic blocking agent, (o-(2-hydroxy-3-(tert. butylamino)-propoxyl)-benzonitrile, Kö 1366)].
    Gilfrich HJ; Rahn KH; Nicolescu RF
    Arzneimittelforschung; 1973 Jun; 23(6):768-71. PubMed ID: 4146902
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis and beta-adrenergic antagonist activity of novel (3-oxazolinyl-1,4-dihydropyridyl) propanolamines.
    Vo D; Wolowyk MW; Knaus EE
    Drug Des Discov; 1992 Jul; 8(4):265-72. PubMed ID: 1359908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver tumors induced by a new beta-adrenoreceptor blocking agent in female rats.
    Ragnotti G; Presta M; Riboni L; Zavanella T
    J Natl Cancer Inst; 1982 Apr; 68(4):669-72. PubMed ID: 6121925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of the new beta-adrenoceptor blocker SL 75212 in man after repeated oral administration [proceedings].
    Bianchetti G; Blatrix C; Gomeni R; Kilborn JR; Larribaud J; Lücker PW; Morselli PL; Thébault JJ; Trocherie S
    Br J Clin Pharmacol; 1979 Oct; 8(4):408P. PubMed ID: 41560
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis and beta-adrenergic blocking activity of oxipropanolamines of 3,4-dihydro-3-oxo-2H(1,4)benzothiazine.
    Cecchetti V; Fravolini A; Fringuelli R; Schiaffella F; Mascellani G; Pagella PG; Rugarli PL
    Farmaco Sci; 1987 Jan; 42(1):61-75. PubMed ID: 2898382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of bronchial effects following topical administration of butylamino-phenoxy-propanol-acetate, an oculoselective beta-adrenoceptor blocker in asthmatic subjects.
    Bauer KG; Brunner-Ferber F; Distlerath LM; Lippa EA; Binkowitz B; Till P; Kaik GA
    Br J Clin Pharmacol; 1992 Aug; 34(2):122-9. PubMed ID: 1358158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.